Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2- Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors

Abstract

Finally, we conclude that our target compounds could be highly beneficial for diabetic patients in the clinic.